Incorporation of liquid lipid in lipid nanoparticles for ocular drug delivery enhancement

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Nanotechnology

• Publication date

  2010-01-15

• Fields of study

  Medicine, Materials Science, Physics

• Identifiers
  DOI 10.1088/0957-4484/21/2/025101PMID 19955616
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery.

  2009cited by this paper
• Cyclosporine-loaded solid lipid nanoparticles (SLN): drug-lipid physicochemical interactions and characterization of drug incorporation.

  2008cited by this paper
• Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC.

  2008cited by this paper
• Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity.

  2008cited by this paper
• A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers.

  2008cited by this paper
• Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells.

  2008cited by this paper
• Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).

  2007cited by this paper
• Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification.

  2007cited by this paper
• Preparation and characterization of monocaprate nanostructured lipid carriers

  2007cited by this paper
• Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance.

  2006cited by this paper
• Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system.

  2005cited by this paper
• Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery.

  2004cited by this paper
• Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery

  2004cited by this paper
• Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations.

  2004cited by this paper
• Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use.

  2004cited by this paper
• Vesicular systems in ocular drug delivery: an overview.

  2004cited by this paper
• Properties and stability of a liquid crystal form of cyclosporine-the first reported naturally occurring peptide that exists as a thermotropic liquid crystal.

  2003cited by this paper
• Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine.

  2002cited by this paper
• Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations.

  2002cited by this paper
• Topical Cyclosporin A in the Management of Therapeutic Keratoplasty for Mycotic Keratitis

  2002cited by this paper
• Production of lipospheres as carriers for bioactive compounds.

  2002cited by this paper
• Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin.

  2002cited by this paper
• Nanostructured lipid matrices for improved microencapsulation of drugs.

  2002cited by this paper
• Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.

  2001cited by this paper
• Topical cyclosporin A in the management of vernal keratoconjunctivitis

  2001cited by this paper
• Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids.

  2000cited by this paper
• Carbopol/pluronic phase change solutions for ophthalmic drug delivery.

  2000cited by this paper
• Biopharmaceutical Considerations In Topical Ocular Drug Delivery

  2000cited by this paper
• Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase.

  1999cited by this paper
• Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain.

  1999cited by this paper
• Investigations on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction

  1993cited by this paper
• Pilocarpine bioavailability from a mucoadhesive liposomal ophthalmic drug delivery system

  1992cited by this paper

• In vitro and in vivo studies of ocular topically administered NLC for the treatment of uveal melanoma.

  2024cites this paper
• Preparation and characterisation of esculetin-loaded nanostructured lipid carriers gels for topical treatment of UV-induced psoriasis

  2024cites this paper
• Exploring the Therapeutic Potential of Cyclosporine for Ophthalmic Indications by Novel Carrier Systems.

  2023cites this paper
• Nano-based eye drop: topical and noninvasive therapy for ocular diseases.

  2023cites this paper
• Recent Advances in Improving the Bioavailability of Hydrophobic/Lipophilic Drugs and Their Delivery via Self-Emulsifying Formulations

  2023cites this paper
• Design, preparation, and in vitro characterizations of chitosan-loaded nanostructured lipid carriers: a promising drug delivery system

  2023cites this paper
• Assessment of Nasal-Brain-Targeting Efficiency of New Developed Mucoadhesive Emulsomes Encapsulating an Anti-Migraine Drug for Effective Treatment of One of the Major Psychiatric Disorders Symptoms

  2022cites this paper
• Polymeric Nanoparticles in Hybrid Catalytic Processing and Drug Delivery System

  2022cites this paper
• Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery

  2022cites this paper
• Spanlastics nanovesicular ocular insert as a novel ocular delivery of travoprost: optimization using Box–Behnken design and in vivo evaluation

  2022cites this paper
• Refinement of Simvastatin and Nifedipine combined delivery through multivariate conceptualization and optimization of the nanostructured lipid carriers

  2021cites this paper
• Topical ocular delivery of vancomycin loaded cationic lipid nanocarriers as a promising and non-invasive alternative approach to intravitreal injection for enhanced bacterial endophthalmitis management.

  2021cites this paper
• Essential Oil and Hydrophilic Antibiotic Co-Encapsulation in Multiple Lipid Nanoparticles: Proof of Concept and In Vitro Activity against Pseudomonas aeruginosa

  2021cites this paper
• Lipid and Polymeric Nanoparticles: Drug Delivery Applications

  2020cites this paper
• Integrative Nanomedicine for New Therapies

  2020cites this paper
• Advances in ophthalmic preparation: the role of drug nanocrystals and lipid-based nanosystems

  2020cites this paper
• Engineering materials

  2020cites this paper
• Target strategies for drug delivery bypassing ocular barriers

  2020cites this paper
• Nanostructured Lipid Carriers to Mediate Brain Delivery of Temazepam: Design and In Vivo Study

  2020cites this paper
• Nanostructured Lipid Carriers to Mediate Brain Delivery of Temazepam: Design and In Vivo Study

  2020cites this paper
• A new medium-throughput screening design approach for the development of hydroxymethylnitrofurazone (NFOH) nanostructured lipid carrier for treating leishmaniasis.

  2020cites this paper
• Hydrocortisone loaded poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for topical ophthalmic administration: preparation, characterization and evaluation of ophthalmic toxicity.

  2019cites this paper
• Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release

  2018cites this paper
• Preparation and characterization of nanostructured lipid carriers as drug delivery system: Influence of liquid lipid types on loading and cytotoxicity.

  2018cites this paper
• Nanostructured lipid carriers for intraocular brimonidine localisation: development, in-vitro and in-vivo evaluation

  2018influential citation
• Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases

  2018cites this paper
• Ocular Delivery System for Propranolol Hydrochloride Based on Nanostructured Lipid Carrier

  2018cites this paper
• Targeted Nanostructured Lipid Carrier for Brain Delivery of Artemisinin: Design, Preparation, Characterization, Optimization and Cell Toxicity.

  2018cites this paper
• Lipid-based nanocarriers for ocular drug delivery

  2017cites this paper
• Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye – Part II ‐ Ocular drug‐loaded lipid nanoparticles

  2017cites this paper
• Designing lipid nanoparticles for topical ocular drug delivery.

  2017cites this paper
• Engineering effective nanoscale nutrient carriers

  2017cites this paper
• Nevirapine Loaded Core Shell Gold Nanoparticles by Double Emulsion Solvent Evaporation: In vitro and In vivo Evaluation.

  2016cites this paper
• Influence of Lipid Core Material on Physicochemical Characteristics of an Ursolic Acid-Loaded Nanostructured Lipid Carrier: An Attempt To Enhance Anticancer Activity.

  2016cites this paper
• Preparation of a paclitaxel-loaded cationic nanoemulsome and its biodistribution via direct intratumoral injection.

  2016cites this paper
• Compound release from nanostructured lipid carriers (NLCs)

  2016cites this paper
• Transport and release in nano-carriers for food applications

  2016cites this paper
• Ex vivo and In vivo Evaluation of Chitosan Coated Nanostructured Lipid Carriers for Ocular Delivery of Acyclovir.

  2016cites this paper
• Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate

  2016cites this paper
• Smart Lipid-Based Drug Delivery Systems

  2016cites this paper
• Development of a topical ocular drug delivery system using polymeric nanoparticles

  2016cites this paper
• Enhanced corneal permeation and antimycotic activity of itraconazole against Candida albicans via a novel nanosystem vesicle

  2016cites this paper
• Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation.

  2016cites this paper
• Development and Preliminary In vitro Evaluation of Nanomicelles Laden In situ Gel of Dexamethasone for Ophthalmic Delivery

  2015cites this paper
• Lipid Nanoparticles for Ocular Gene Delivery

  2015influential citation
• Effect of distribution of solid and liquid lipid domains on transport of free radicals in nanostructured lipid carriers

  2015cites this paper
• Lipid nanocarriers (LNC) and their applications in ocular drug delivery.

  2015cites this paper
• Ophthalmic applications of lipid-based drug nanocarriers: an update of research and patenting activity.

  2015cites this paper
• Development and Evaluation of Nanoemulsifying Preconcentrate of Curcumin for Colon Delivery

  2015cites this paper
• Supercritical fluid precipitation of ketoprofen in novel structured lipid carriers for enhanced mucosal delivery--a comparison with solid lipid particles.

  2015cites this paper
• Preparation and in vitro-in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis.

  2014cites this paper
• Topical delivery of ocular therapeutics: carrier systems and physical methods

  2014cites this paper
• Potential of Nanomaterials as Movers and Packers for Drug Molecules

  2014cites this paper
• Nanostructured lipid carriers: effect of solid phase fraction and distribution on the release of encapsulated materials.

  2014cites this paper
• High melting lipid based approach for drug delivery: solid lipid nanoparticles.

  2013cites this paper
• Solidification of nanostructured lipid carriers (NLCs) onto pellets by fluid-bed coating: Preparation, in vitro characterization and bioavailability in dogs

  2013cites this paper
• Computational design of a CNT carrier for a high affinity bispecific anti-HER2 antibody based on trastuzumab and pertuzumab Fabs

  2013cites this paper
• Preparation and characterization of Paliperidone loaded solid lipid nanoparticles.

  2013cites this paper
• Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir

  2013cites this paper
• Lipid Nanoparticles as Drug/Gene Delivery Systems to the Retina

  2013cites this paper
• Enhanced payload of lipid nanocarriers using supersaturated solution prepared by solvent-mediated method

  2013cites this paper
• Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation

  2013cites this paper
• Design and Development of Solid Lipid Nanoparticles for Ocular Delivery of Acyclovir

  2013cites this paper
• Absorption, disposition and pharmacokinetics of solid lipid nanoparticles.

  2012cites this paper
• Influence of Formulation Variables of Nanostructured Lipid Carriers on Their Physicochemical and Drug Release Properties

  2012cites this paper
• Optimization of LDL targeted nanostructured lipid carriers of 5-FU by a full factorial design

  2012cites this paper
• Development of mucoadhesive drug delivery system using phenylboronic acid functionalized poly(D,L-lactide)-b-dextran nanoparticles.

  2012cites this paper
• Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma

  2012cites this paper
• Enhanced payload and photo-protection for pesticides using nanostructured lipid carriers with corn oil as liquid lipid

  2012cites this paper
• Improved and safe transcorneal delivery of flurbiprofen by NLC and NLC-based hydrogels.

  2012cites this paper
• Lipid nanocarriers: influence of lipids on product development and pharmacokinetics.

  2011cites this paper
• Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery

  2011cites this paper
• Preparation of a cationic nanoemulsome for intratumoral drug delivery and its enhancing effect on cellular uptake in vitro.

  2011cites this paper
• Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: Improving in vivo ocular distribution.

  2010cites this paper
• Solid lipid nanoparticles for ocular drug delivery

  2010influential citation